Cytokinetics | CYTK - Gross Profit On Sales


Cytokinetics reported $23.03M in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
Acadia Pharmaceuticals USD 279.64M 36.37M Jun/2026
Amgen USD 5.87B 1.02B Mar/2026
Arca Biopharma 0 0 Mar/2025
Bayer EUR 6.33B 1.84B Jun/2026
Biogen USD 2.12B 307M Jun/2026
Bristol-Myers Squibb USD 9.26B 1.19B Jun/2026
Capricor Therapeutics 11.13M 8.87M Dec/2024
Cytokinetics USD 23.03M 3.84M Jun/2026
Eisai JPY 183.24B 29.83B Jun/2026
Eli Lilly USD 16.22B 301.7M Mar/2026
Exelixis USD 608.03M 17.17M Jun/2026
Geron USD 50.14M 3.44M Mar/2026
Halozyme Therapeutics USD 297.47M 75.53M Mar/2026
Ionis Pharmaceuticals USD 265M 22M Jun/2026
Ligand Pharmaceuticals USD 100.41M 51.96M Jun/2026
Merck USD 12.09B 1.24B Mar/2026
Novartis USD 11.24B 1.18B Jun/2026
Pfizer USD -248M 11.29B Jun/2026
Regeneron Pharmaceuticals USD 3.71B 778.2M Jun/2026
Roche Holding CHF 22.69B 600M Jun/2026
Sanofi EUR 8.71B 602M Jun/2026